By David Li, bostonese.com
Cambridge, Mass., Dec. 10, 2013, — The 2013 Medical Device and Diagnostics Innovation (MDDI) Symposium was held on Dec. 7 at IBM Innovation Center on One Rogers Street. Over 100 attendees packed the lecture hall during the day-long symposium.
|
|
The MDDI symposium aims to build a platform of interaction for biomedical professionals in the New England area, highlight innovation and marketing trends. It also helps uncover opportunities for entrepreneurship in both US and China by bringing together researchers, experts and entrepreneurs from both countries.
The MDDI symposium was co-presented by Chinese-American BioMedical Association (CABA), New England Chinese Information and Networking Association (NECINA), American Chinese Medical Association (ACMA), and Harvard Medical School- Chinese Scholars and Scientists Association (HMS-CSSA). According to Ellen Fan, last year’s symposium was held at IBM Innovation Center in Waltham, Mass.. Ms. Fan thanked IBM’s sponsorship for this event. |
Ru Zheng, president of NECINA, hosted the MDDI symposium. Speakers included leading researchers and entrepreneurs in this field. They shared with the audience various aspects of the medical device industry in the US and in China.
- Laisheng Chou, PhD, Professor and Director, Division of Oral Medicine, Director, Oral AIDS Clinic Henry M. Goldman School of Dental Medicine, Boston University
- Utkam Demiric, PhD, Assist professor, Harvard Medical School
- W. Christopher Fang, MD, MBA, Worldwide VP, Strategic Medical Affairs, DePuySynthes, Johnson & Johnson
- Angelina Hao, MBA, CEO, Normalline
- Peter Y. Li, PhD, CEO, Nexcelom Bioscience
- William Lian, PhD, MD, Assistant Professor, UMass Medical School
- Shen Luan, PhD, Co-Founder and COO, Berg Diagnostic
- James Robertson, COO, MindChild
- Upma Sharma, PhD, Director, Arsenal Medical
- Shallwei Sun, President and General Manager, Callisyn Biomedical
- Jiping Wang, PhD, MD, Assistant Professor, Harvard Medical School
Outside the lecture hall, Jo Lee, Yan ZHou and Emile Bellott were greeting attendees at the Howfond Inc. table. Established in Wuxi, China in 2007, Howfond, Inc. is a research-driven, customer-focused and privately owned biotech company. It has received $15 million investment mainly by US firms. The company provides FTE, CRO and CMO chemistry solutions and services to Pharma and BioTech firms worldwide, and owns 110,000 sq ft lab and 170,000 sq ft production facilities.
(from left) Jo Lee, Emile Bellott and Yan Zhou pose for a picture (photo by David Li).
Dr. Xiang Yu, president of CABA, thanked William Poon, Ellen Fan and other volunteers for their hard work putting together this year’s symposium. She also thanked Howfond Inc. and Mayly Life Sciences for their generous sponsorship.